A citation-based method for searching scientific literature


List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Effect of the JAK2/STAT3 inhibitor SAR317461 on human glioblastoma tumorspheres.
Rajesh Mukthavaram, Xiao Ouyang, Rohit Saklecha, Pengfei Jiang, Natsuko Nomura, Sandeep C Pingle, Fang Guo, Milan Makale, Santosh Kesari. J Transl Med 2015
41
50

Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint.
Jörg Wischhusen, Ignacio Melero, Wolf Herman Fridman. Front Immunol 2020
49
50

Identification of pharmacodynamic biomarkers and common molecular mechanisms of response to genotoxic agents in cancer cell lines.
Dong-Joon Min, Yingdong Zhao, Anne Monks, Alida Palmisano, Curtis Hose, Beverly A Teicher, James H Doroshow, Richard M Simon. Cancer Chemother Pharmacol 2019
3
50

The great escape: tumour cell plasticity in resistance to targeted therapy.
Soufiane Boumahdi, Frederic J de Sauvage. Nat Rev Drug Discov 2020
134
50

Inhibition of SIK2 and SIK3 during differentiation enhances the anti-inflammatory phenotype of macrophages.
Nicola J Darling, Rachel Toth, J Simon C Arthur, Kristopher Clark. Biochem J 2017
31
50

Adaptive Global Innovative Learning Environment for Glioblastoma: GBM AGILE.
Brian M Alexander, Sujuan Ba, Mitchel S Berger, Donald A Berry, Webster K Cavenee, Susan M Chang, Timothy F Cloughesy, Tao Jiang, Mustafa Khasraw, Wenbin Li,[...]. Clin Cancer Res 2018
71
50

Drug Repositioning in Glioblastoma: A Pathway Perspective.
Sze Kiat Tan, Anna Jermakowicz, Adnan K Mookhtiar, Charles B Nemeroff, Stephan C Schürer, Nagi G Ayad. Front Pharmacol 2018
40
50

GDF-15 contributes to proliferation and immune escape of malignant gliomas.
Patrick Roth, Markus Junker, Isabel Tritschler, Michel Mittelbronn, Yvonne Dombrowski, Samuel N Breit, Ghazaleh Tabatabai, Wolfgang Wick, Michael Weller, Jörg Wischhusen. Clin Cancer Res 2010
93
50

Evolving role of regorafenib for the treatment of advanced cancers.
Axel Grothey, Jean-Yves Blay, Nick Pavlakis, Takayuki Yoshino, Jordi Bruix. Cancer Treat Rev 2020
15
50

Heme Oxygenase-1 in Central Nervous System Malignancies.
Giuseppe Sferrazzo, Michelino Di Rosa, Eugenio Barone, Giovanni Li Volti, Nicolò Musso, Daniele Tibullo, Ignazio Barbagallo. J Clin Med 2020
12
50

BDKRB2 is a novel EMT-related biomarker and predicts poor survival in glioma.
Ying Yang, Jin Wang, Fei Shi, Aijun Shan, Shihai Xu, Wen Lv. Aging (Albany NY) 2021
1
100

TCF19 Promotes Cell Proliferation through Binding to the Histone H3K4me3 Mark.
Payel Mondal, Sabyasachi Sen, Brianna J Klein, Niharika Tiwary, Shrikanth S Gadad, Tatiana G Kutateladze, Siddhartha Roy, Chandrima Das. Biochemistry 2020
8
50

Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial.
Giuseppe Lombardi, Gian Luca De Salvo, Alba Ariela Brandes, Marica Eoli, Roberta Rudà, Marina Faedi, Ivan Lolli, Andrea Pace, Bruno Daniele, Francesco Pasqualetti,[...]. Lancet Oncol 2019
88
50

Glioblastoma Stem Cells Respond to Differentiation Cues but Fail to Undergo Commitment and Terminal Cell-Cycle Arrest.
Helena Carén, Stefan H Stricker, Harry Bulstrode, Sladjana Gagrica, Ewan Johnstone, Thomas E Bartlett, Andrew Feber, Gareth Wilson, Andrew E Teschendorff, Paul Bertone,[...]. Stem Cell Reports 2015
56
50

Pharmacogenomics of GPCR Drug Targets.
Alexander S Hauser, Sreenivas Chavali, Ikuo Masuho, Leonie J Jahn, Kirill A Martemyanov, David E Gloriam, M Madan Babu. Cell 2018
241
50

Pharos: Collating protein information to shed light on the druggable genome.
Dac-Trung Nguyen, Stephen Mathias, Cristian Bologa, Soren Brunak, Nicolas Fernandez, Anna Gaulton, Anne Hersey, Jayme Holmes, Lars Juhl Jensen, Anneli Karlsson,[...]. Nucleic Acids Res 2017
112
50

GDF15 and Growth Control.
Paul J Emmerson, Kevin L Duffin, Sudhakar Chintharlapalli, Xinle Wu. Front Physiol 2018
65
50

A Potential Role for the Inhibition of PI3K Signaling in Glioblastoma Therapy.
Stephanie Ströbele, Matthias Schneider, Lukas Schneele, Markus D Siegelin, Lisa Nonnenmacher, Shaoxia Zhou, Georg Karpel-Massler, Mike-Andrew Westhoff, Marc-Eric Halatsch, Klaus-Michael Debatin. PLoS One 2015
28
50

FAM111 protease activity undermines cellular fitness and is amplified by gain-of-function mutations in human disease.
Saskia Hoffmann, Satyakrishna Pentakota, Andreas Mund, Peter Haahr, Fabian Coscia, Marta Gallo, Matthias Mann, Nicholas Mi Taylor, Niels Mailand. EMBO Rep 2020
7
50

Discovery of a novel class of phosphodiesterase 10A inhibitors and identification of clinical candidate 2-[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)-phenoxymethyl]-quinoline (PF-2545920) for the treatment of schizophrenia.
Patrick R Verhoest, Douglas S Chapin, Michael Corman, Kari Fonseca, John F Harms, Xinjun Hou, Eric S Marr, Frank S Menniti, Frederick Nelson, Rebecca O'Connor,[...]. J Med Chem 2009
172
50

HMGCR positively regulated the growth and migration of glioblastoma cells.
Zhihua Qiu, Wen Yuan, Tao Chen, Chenzhi Zhou, Chao Liu, Yongkai Huang, Deqing Han, Qinghui Huang. Gene 2016
20
50

Therapy for glioblastoma: is it working?
Edward D Zanders, Fredrik Svensson, David S Bailey. Drug Discov Today 2019
43
50

The Role of Selected Chemokines and Their Receptors in the Development of Gliomas.
Magdalena Groblewska, Ala Litman-Zawadzka, Barbara Mroczko. Int J Mol Sci 2020
23
50

PiggyBac mutagenesis and exome sequencing identify genetic driver landscapes and potential therapeutic targets of EGFR-mutant gliomas.
Imran Noorani, Jorge de la Rosa, Yoon Ha Choi, Alexander Strong, Hannes Ponstingl, M S Vijayabaskar, Jusung Lee, Eunmin Lee, Angela Richard-Londt, Mathias Friedrich,[...]. Genome Biol 2020
10
50

Small molecules targeting histone demethylase genes (KDMs) inhibit growth of temozolomide-resistant glioblastoma cells.
Barbara Banelli, Antonio Daga, Alessandra Forlani, Giorgio Allemanni, Daniela Marubbi, Maria Pia Pistillo, Aldo Profumo, Massimo Romani. Oncotarget 2017
22
50

Down-regulation of TRIB3 inhibits the progression of ovarian cancer via MEK/ERK signaling pathway.
Shuang Wang, Caixia Wang, Xiao Li, Yuexin Hu, Rui Gou, Qian Guo, Xin Nie, Juanjuan Liu, Liancheng Zhu, Bei Lin. Cancer Cell Int 2020
9
50

Gene signatures of quiescent glioblastoma cells reveal mesenchymal shift and interactions with niche microenvironment.
Rut Tejero, Yong Huang, Igor Katsyv, Michael Kluge, Jung-Yi Lin, Jessica Tome-Garcia, Nicolas Daviaud, Yuanshuo Wang, Bin Zhang, Nadejda M Tsankova,[...]. EBioMedicine 2019
38
50

Phosphodiesterase 10A Inhibitor Monotherapy Is Not an Effective Treatment of Acute Schizophrenia.
David P Walling, Anindita Banerjee, Vikas Dawra, Stacey Boyer, Christopher J Schmidt, Nicholas DeMartinis. J Clin Psychopharmacol 2019
4
50

Nuciferine inhibits the progression of glioblastoma by suppressing the SOX2-AKT/STAT3-Slug signaling pathway.
Zizhuo Li, Yaodong Chen, Tingting An, Pengfei Liu, Jiyuan Zhu, Haichao Yang, Wei Zhang, Tianxiu Dong, Jian Jiang, Yu Zhang,[...]. J Exp Clin Cancer Res 2019
33
50

Complex Cartography: Regulation of E2F Transcription Factors by Cyclin F and Ubiquitin.
Michael J Emanuele, Taylor P Enrico, Ryan D Mouery, Danit Wasserman, Sapir Nachum, Amit Tzur. Trends Cell Biol 2020
11
50

A Network Analysis of Multiple Myeloma Related Gene Signatures.
Yu Liu, Haocheng Yu, Seungyeul Yoo, Eunjee Lee, Alessandro Laganà, Samir Parekh, Eric E Schadt, Li Wang, Jun Zhu. Cancers (Basel) 2019
10
50


Downregulation of the CCL2/CCR2 and CXCL10/CXCR3 axes contributes to antitumor effects in a mouse model of malignant glioma.
Kenji Shono, Izumi Yamaguchi, Yoshifumi Mizobuchi, Hiroshi Kagusa, Akiko Sumi, Toshitaka Fujihara, Kohei Nakajima, Keiko T Kitazato, Kazuhito Matsuzaki, Hideyuki Saya,[...]. Sci Rep 2020
9
50

The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma.
Barbara Banelli, Elisa Carra, Federica Barbieri, Roberto Würth, Federica Parodi, Alessandra Pattarozzi, Roberta Carosio, Alessandra Forlani, Giorgio Allemanni, Daniela Marubbi,[...]. Cell Cycle 2015
61
50

Phosphatases and solid tumors: focus on glioblastoma initiation, progression and recurrences.
Matthias Dedobbeleer, Estelle Willems, Stephen Freeman, Arnaud Lombard, Nicolas Goffart, Bernard Rogister. Biochem J 2017
9
50

How were new medicines discovered?
David C Swinney, Jason Anthony. Nat Rev Drug Discov 2011
50

The nonpeptide WIN 64338 is a bradykinin B2 receptor antagonist.
D G Sawutz, J M Salvino, R E Dolle, F Casiano, S J Ward, W T Houck, D M Faunce, B D Douty, E Baizman, M M Awad. Proc Natl Acad Sci U S A 1994
83
50

Multifunctional protein APPL2 contributes to survival of human glioma cells.
Beata Pyrzynska, Magdalena Banach-Orlowska, Marta Teperek-Tkacz, Katarzyna Miekus, Grazyna Drabik, Marcin Majka, Marta Miaczynska. Mol Oncol 2013
14
50

Small-molecule screening identifies inhibition of salt-inducible kinases as a therapeutic strategy to enhance immunoregulatory functions of dendritic cells.
Thomas B Sundberg, Hwan Geun Choi, Joo-Hye Song, Caitlin N Russell, Mahmud M Hussain, Daniel B Graham, Bernard Khor, John Gagnon, Daniel J O'Connell, Kavitha Narayan,[...]. Proc Natl Acad Sci U S A 2014
44
50



Pleiotropic effects of statins: A focus on cancer.
Mazaher Ahmadi, Shayan Amiri, Stevan Pecic, Filip Machaj, Jakub Rosik, Marek J Łos, Javad Alizadeh, Reza Mahdian, Simone C da Silva Rosa, Dedmer Schaafsma,[...]. Biochim Biophys Acta Mol Basis Dis 2020
22
50

Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies.
F J Hock, K Wirth, U Albus, W Linz, H J Gerhards, G Wiemer, S Henke, G Breipohl, W König, J Knolle. Br J Pharmacol 1991
687
50

GBM Drug Bank-a new resource for glioblastoma drug discovery and informatics research.
Fredrik Svensson, Bart Westerman, Thomas Würdinger, David Bailey. Neuro Oncol 2018
3
50

A panel of five plasma proteins for the early diagnosis of hepatitis B virus-related hepatocellular carcinoma in individuals at risk.
Kai Cheng, Jie Shi, Zixin Liu, Yin Jia, Qin Qin, Hui Zhang, Siqin Wan, Ziguang Niu, Lei Lu, Juxian Sun,[...]. EBioMedicine 2020
5
50

A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care.
Richard E Kast, John A Boockvar, Ansgar Brüning, Francesco Cappello, Wen-Wei Chang, Boris Cvek, Q Ping Dou, Alfonso Duenas-Gonzalez, Thomas Efferth, Daniele Focosi,[...]. Oncotarget 2013
115
50

Illuminating the Onco-GPCRome: Novel G protein-coupled receptor-driven oncocrine networks and targets for cancer immunotherapy.
Victoria Wu, Huwate Yeerna, Nijiro Nohata, Joshua Chiou, Olivier Harismendy, Francesco Raimondi, Asuka Inoue, Robert B Russell, Pablo Tamayo, J Silvio Gutkind. J Biol Chem 2019
59
50

GPR37 surface expression enhancement via N-terminal truncation or protein-protein interactions.
Jill H Dunham, Rebecca C Meyer, Erin L Garcia, Randy A Hall. Biochemistry 2009
49
50


Combenefit: an interactive platform for the analysis and visualization of drug combinations.
Giovanni Y Di Veroli, Chiara Fornari, Dennis Wang, Séverine Mollard, Jo L Bramhall, Frances M Richards, Duncan I Jodrell. Bioinformatics 2016
227
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.